Preimplantation Genetic Testing Market Key Players, Financial Overview and Analysis Report Forecast to 2027
It is estimated that the global preimplantation genetic testing market is expected to register a CAGR of 10.2% during the forecast period of 2019 to 2025, with a market value of USD 375.8 million in 2018.
Preimplantation genetic testing is the testing at the
pre-implantation stage for detection of genetic defects in embryos or oocytes.
Preimplantation genetic testing has occurred more frequently in recent years in
North America and Europe, due to the advancement in genetic technology.
The decreasing fertility rates worldwide enhance the
acceptance of the preimplantation genetic testing to avoid further
complications of chromosomal abnormalities with advancing maternal age. This
leads to the growth of the preimplantation genetic testing market during the
forecast period. According to the Vital Statistics Rapid Release, the total
fertility rate for the US in 2017 was 1,764.5 births per 1,000 women, and in
2016 it was 1,820.5, which is 3% less, this shows the reduction in the
rate of fertility.
An increasing number of fertility clinics worldwide, new
development technological advancements in the field of genetic analysis
and high threat of chromosomal abnormalities with advancing maternal age
are the other driving factors for global preimplantation
genetic testing market
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/8121
Key Players
Some of the major players in the global preimplantation
genetic testing market are Natera, Inc.CooperSurgical, Inc., F. Hoffmann-La
Roche AG, Illumina, Inc., IGENOMIX, Reprogenetics, LLC, Genea Limited,
PerkinElmer, Inc., Genesis Genetics Ltd., Quest Diagnostics Incorporated,
Thermo FisherScientific, Inc, Bioarrayn Genetics, Laboratory Corporation of
America Holdings, California Pacific Medical Center and Reproductive Health
Science Ltd
Segmentation
The global preimplantation genetic testing market is
segmented based on procedure, type, application, technology, product and
service, end user, and region.
The global market for preimplantation genetic testing, by
procedure, is segmented into preimplantation genetic diagnosis (PGD) and
preimplantation genetic screening (PGS). Hundred different genetic conditions
can be tested with Preimplantation Genetic Diagnosis (PGD) which enables the
couple to have a baby with no genetic defect thus the segment is expected to
hold the largest market share owing to rising awareness population and
healthcare experts. Preimplantation Genetic Screening (PGS) segment is also
anticipated to grow profitably to increase healthy pregnancy.
By type, embryo testing segment is expected to show
favorable growth as the threat of chromosomal abnormalities increases. By
product and service, the reagents and consumables segment anticipated to hold
the largest market share as there is continuous declination infertility of female
due to increasing usage of reagents for the diagnosis. By technology, the
next-generation sequencing segment, and comparative genomic hybridization also
expected to hold large share as its cost is reduced and its capability to
detect mosaicism. The market by end user has been segmented into maternity
centers & fertility clinics
hospitals, diagnostic labs and research laboratories &
academic institutes. Based on region, the global preimplantation genetic
testing market is segmented into the Americas, Europe, Asia-Pacific, and the
Middle East and Africa.
Regional Analysis
The market has been divided, by region, into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa. The global
preimplantation genetic testing market in the Americas has further been
branched into North America and Latin America, with the North American market
divided into the US and Canada. The European global preimplantation genetic
testing market has been sub-divided Western Europe and Eastern Europe. Western
Europe has further been classified as Germany, France, UK, Italy, Spain, and
the rest of Western Europe. The global preimplantation genetic testing market
in Asia-Pacific has been segmented into Japan, China, India, South Korea,
Australia, and the rest of Asia-Pacific. The IPF treatment market in the Middle
East & Africa has been divided into the Middle East and Africa.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/preimplantation-genetic-testing-market-8121
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
More Related Report
Stroke Diagnosis and Treatment Market
Comments
Post a Comment